Inactive Instrument

EIS Eczacibs Ilc Sn Fnsl Ytrmlr Sny Tcrt Stock Borsa Istanbul

Equities

TRAECILC91E0

Pharmaceuticals

End-of-day quote Borsa Istanbul
- TRY - Intraday chart for EIS Eczacibs Ilc Sn Fnsl Ytrmlr Sny Tcrt
Sales 2022 1.83B 56.49M Sales 2023 6.48B 200M Capitalization 30.12B 930M
Net income 2022 4.18B 129M Net income 2023 2.74B 84.56M EV / Sales 2022 12.6 x
Net Debt 2022 1.01B 31.25M Net Debt 2023 862M 26.59M EV / Sales 2023 4.78 x
P/E ratio 2022
5.28 x
P/E ratio 2023
11 x
Employees -
Yield 2022
1.27%
Yield 2023
-
Free-Float 18.77%
More Fundamentals * Assessed data
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.(IBSE:ECILC) added to FTSE All-World Index CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Eis Eczacibasi Ilaç, Sinai Ve Finansal Yatirimlar Sanayi Ve Ticaret A.S. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Sesen Bio and Eczacibasi Pharmaceuticals Marketing Enter into Licensing Agreement CI
Eis Eczacibasi Ilaç, Sinai Ve Finansal Yatirimlar Sanayi Ve Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Eis Eczacibasi Ilaç, Sinai Ve Finansal Yatirimlar Sanayi Ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
More news
Managers TitleAgeSince
Chief Executive Officer - 22-08-31
Investor Relations Contact - 11-08-30
Members of the board TitleAgeSince
Chairman - 81-04-02
Director/Board Member 57 18-04-11
Director/Board Member 70 -
More insiders
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS, formerly known as Eczacibasi Ilac Sanayi ve Ticaret A.S., (EIS) is a Turkey-based company active in the pharmaceutical industry through its subsidiaries, affiliates and joint ventures. Its product portfolio consists of drugs for human health, veterinary drugs and personal care products, such as body and facial creams, hair gels, deodorants and various other products. The Company is also engaged in real estate development and construction through its subsidiary, Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., formerly known as Eczacibasi Insaat ve Ticaret A.S. Its subsidiaries also include Eczacibasi Ilac Ticaret A.S. (EIT), EHP Eczacibasi Health Care Products Joint Stock Co. (EHP), and Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., among others. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a member of Eczacibasi Group of Companies.
More about the company